Weekly influenza surveillance overview, Nov 15, 2013 - week 45
During week 45/2013: All 27 reporting countries experienced low intensity influenza activity.
Weekly influenza surveillance overview, Nov 22, 2013 - week 46
During week 46/2013: All 28 reporting countries experienced low intensity influenza activity
Meeting report: Joint WHO Regional Office for Europe/ECDC Meeeting on Influenza Surveillance 2013
The third joint WHO European Regional Office for Europe/ECDC annual influenza surveillance meeting.
4th Joint WHO/Europe–ECDC Annual European Influenza Surveillance Meeting 2014
WHO/Europe has been holding annual influenza surveillance meetings jointly with the European Centre for Disease Prevention and Control (ECDC) since 2011. This meeting brought together epidemiologists and virologists – the national influenza surveillance focal points – from 50 Member States to discuss national, regional and global surveillance related to seasonal influenza and novel influenza viruses, such as avian influenza A(H7N9).
Factsheet about seasonal influenza
Influenza is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and sometimes the lungs. It can cause mild to severe illness, and at times can lead to death. The best way to prevent flu is by getting a flu vaccine each year.
Surveillance reports for the 2009 influenza A (H1N1) pandemic
Page listing surveillance reports for the 2009 influenza A (H1N1) pandemic. The 2009 influenza A(H1N1) pandemic was declared over in August 2010 by the World Health Organization. Europe has now entered a new inter-pandemic phase of seasonal influenza.
WHO recommendations for influenza virus vaccine composition for the 2018 southern hemisphere influenza season
The World Health Organization (WHO) has recommended the composition of the trivalent influenza vaccine for the southern hemisphere winter 2018 influenza season in a report published 28 September 2017.
WHO Guidance for Surveillance during an Influenza Pandemic
This guidance is an update to an earlier document “Global surveillance during an influenza pandemic”, published in April 2009. It takes the lesions learned from the 2009 influenza pandemic into consideration and focuses on the key surveillance components needed during an influenza pandemic. The purpose of the updated guidance is to outline the surveillance strategies and essential data requirements that Member States can use throughout the course of an influenza pandemic to ensure informed risk management decisions in pandemic response and fulfilment of IHR (2005) core capacity requirements.
WHO Europe: Influenza
WHO/Europe aim to reduce influenza-related morbidity and mortality by strengthening virological and epidemiological surveillance for mild and severe influenza; using surveillance data to estimate the burden of influenza in order to prioritize national influenza vaccination programmes; and maintaining and strengthening pandemic preparedness activities at the national level. WHO/Europe also monitors the emergence of other respiratory pathogens that have the potential to spread among humans. These include coronaviruses, which cause a range of illnesses from severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome coronavirus (MERS-CoV) to the common cold.